SEER Q2 2021 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena

SEERSeer, Inc.

$98M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+1778.9% YoY

Gross Profit

$188,00014.1% margin

Operating Income

-$17M-1249.7% margin

Net Income

-$17M-1245.6% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$12M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$537M

Total Liabilities

$11M

Stockholders' Equity

$526M

Cash & Equivalents

$371M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$71,000	+1778.9%
Gross Profit	$188,000	$71,000	+164.8%
Operating Income	-$17M	-$6M	-161.8%
Net Income	-$17M	-$6M	-171.6%

Revenue Segments

Product

$837,00063%

Related Party

$380,00028%

Grant

$117,0009%